INIS
hiv
100%
patients
89%
women
49%
malawi
49%
risks
41%
humans
34%
cancer
34%
levels
32%
therapy
29%
data
26%
comparative evaluations
25%
control
23%
populations
20%
interventions
20%
adolescents
19%
diseases
18%
people
18%
children
16%
inflammation
15%
females
15%
mice
14%
males
14%
workers
14%
death
14%
viruses
14%
esophagus
13%
tissues
12%
drugs
12%
lungs
11%
interleukins
11%
retention
11%
incidents
11%
doses
11%
detection
10%
management
10%
probability
10%
cost
10%
sex
9%
validation
9%
genes
9%
hospitals
9%
symptoms
9%
plasma
9%
income
9%
hepatomas
8%
markov process
8%
breasts
8%
barriers
8%
adenocarcinomas
8%
burnout
8%
Medicine and Dentistry
Human Immunodeficiency Virus
49%
Woman
36%
Patient
26%
Inpatient
14%
Antiretroviral Therapy
13%
Child
11%
Association
11%
Experience
10%
Health Care
9%
Patient Compliance
8%
Barrett Esophagus
8%
Childhood
8%
Recurrent Disease
8%
Follow up
8%
Incidence
8%
Therapeutic Procedure
8%
Hospital
7%
Age
7%
Prevalence
7%
Infant
6%
Medicare
6%
Screening
5%
Neoplasm
5%
Adverse Event
5%
Development
5%
Life
5%
Diabetes
5%
Comprehension
5%
Male
5%
Veterans Affairs
5%
Keyphrases
People Living with HIV (PLHIV)
8%
Interleukin-6
8%
Malawi
8%
Confidence Interval
6%
Vaginal Intraepithelial Neoplasia (VaIN)
5%
Retrospective Cohort Study
5%
Pregnant Women Living with HIV
5%
